https://www.selleckchem.com/products/PLX-4032.html
05). We observed a marginally lower relative abundance of bacteria belonging to Clostridium group IV in PD patients who experienced a medium or large improvement in motor impairment in response to Levodopa compared to those with a small response [β = -0.64 (SE 0.18), p-trend 0.00015 p-FDR 0.019]. Conclusions In this study, Levodopa was not associated with changes in microbiota composition in this longitudinal analysis. The association between abundance of Clostridium group IV and short-term motor symptom response to Levodopa is prelimi
Like
Comment
Share
